@article{01c3c8a6fd594272b510a99c7ab89694,
title = "Machine learning-assisted neurotoxicity prediction in human midbrain organoids",
abstract = "Introduction: Brain organoids are highly complex multi-cellular tissue proxies, which have recently risen as novel tools to study neurodegenerative diseases such as Parkinson's disease (PD). However, with increasing complexity of the system, usage of quantitative tools becomes challenging. Objectives: The primary objective of this study was to develop a neurotoxin-induced PD organoid model and to assess the neurotoxic effect on dopaminergic neurons using microscopy-based phenotyping in a high-content fashion. Methods: We describe a pipeline for a machine learning-based analytical method, allowing for detailed image-based cell profiling and toxicity prediction in brain organoids treated with the neurotoxic compound 6-hydroxydopamine (6-OHDA). Results: We quantified features such as dopaminergic neuron count and neuronal complexity and built a machine learning classifier with the data to optimize data processing strategies and to discriminate between different treatment conditions. We validated the approach with high content imaging data from PD patient derived midbrain organoids. Conclusions: The here described model is a valuable tool for advanced in vitro PD modeling and to test putative neurotoxic compounds.",
keywords = "Machine learning, Midbrain organoids, Neurotoxicity, Parkinson's disease",
author = "Monzel, {Anna S.} and Kathrin Hemmer and Tony Kaoma and Smits, {Lisa M.} and Silvia Bolognin and Philippe Lucarelli and Isabel Rosety and Alise Zagare and Paul Antony and Nickels, {Sarah L.} and Rejko Krueger and Francisco Azuaje and Schwamborn, {Jens C.}",
note = "Funding Information: This work was supported by a Proof-of-Concept grant from the Fonds National de la Recherche (FNR) Luxembourg (FNR/PoC16/11559169). Further, this is an EU Joint Program - Neurodegenerative Disease Research (JPND) project (INTER/JPND/14/02; INTER/JPND/15/11092422) receiving funding from the FNR. A.S.M., L.M.S., and I.R. were supported by FNR Aides ? la Formation-Recherche (AFR). A.S.M. received support from the Lush prize 2017.We thank Prof. Dr. Hans R. Sch?ler of the Max Planck Institute, Prof. Dr. Thomas Gasser of the Hertie Institute in T?bingen and the Coriell Institute for providing cell lines. Microscopy was supported by the LCSB bio-imaging platform. We thank the Disease Modeling Screening Platform from LCSB and LIH for their help with performing automated and high-throughput procedures. This work was supported by a Proof-of-Concept grant from the Fonds National de la Recherche (FNR) Luxembourg (FNR/PoC16/11559169). Further, this is an EU Joint Program - Neurodegenerative Disease Research (JPND) project (INTER/JPND/14/02; INTER/JPND/15/11092422) receiving funding from the FNR. A.S.M. L.M.S. and I.R. were supported by FNR Aides ? la Formation-Recherche (AFR). A.S.M. received support from the Lush prize 2017. We also thank the private donors who support our work at the Luxembourg Center for Systems Biomedicine. Funding Information: We thank Prof. Dr. Hans R. Sch{\"o}ler of the Max Planck Institute, Prof. Dr. Thomas Gasser of the Hertie Institute in T{\"u}bingen and the Coriell Institute for providing cell lines. Microscopy was supported by the LCSB bio-imaging platform . We thank the Disease Modeling Screening Platform from LCSB and LIH for their help with performing automated and high-throughput procedures. This work was supported by a Proof-of-Concept grant from the Fonds National de la Recherche (FNR) Luxembourg ( FNR/PoC16/11559169 ). Further, this is an EU Joint Program - Neurodegenerative Disease Research (JPND) project ( INTER/JPND/14/02 ; INTER/JPND/15/11092422 ) receiving funding from the FNR . A.S.M., L.M.S., and I.R. were supported by FNR Aides {\`a} la Formation-Recherche (AFR) . A.S.M. received support from the Lush prize 2017. We also thank the private donors who support our work at the Luxembourg Center for Systems Biomedicine. Funding Information: This work was supported by a Proof-of-Concept grant from the Fonds National de la Recherche (FNR) Luxembourg ( FNR/PoC16/11559169 ). Further, this is an EU Joint Program - Neurodegenerative Disease Research (JPND) project ( INTER/JPND/14/02 ; INTER/JPND/15/11092422 ) receiving funding from the FNR . A.S.M., L.M.S., and I.R. were supported by FNR Aides {\`a} la Formation-Recherche (AFR) . A.S.M. received support from the Lush prize 2017. Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2020",
month = jun,
doi = "10.1016/j.parkreldis.2020.05.011",
language = "English",
volume = "75",
pages = "105--109",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
}